Feb. 4 at 3:34 AM
$CURLF $TLRY $ACB
Curaleaf (CURLF) is experiencing significant international growth, with Q2 2025 international revenue rising 67% to
$75.8 million, up from
$45.3 million in the same period of 2024. Driven by expansion in Europe and a new license in Turkey, this international sector is a major growth driver for the company.
Key highlights regarding Curaleaf international sales (based on 2025 reports):
Strong Growth: International sales saw high year-over-year increases, such as 56% in Q3 2025 and 67% in Q2 2025.
Strategic Markets: Curaleaf International has a strong presence in the UK, Portugal, Spain, and Germany.
Expansion: The company continues to expand its international footprint, with new operations in Turkey, to capitalize on global demand.
Revenue Contribution: While domestic (U.S.) sales have faced challenges, international momentum has helped offset those pressures, contributing to overall company strategy and performance.